Institution
Barts Cancer Institute
Also known as: BCI
- 3running trials
- 4closed trials
- 5,789publications (OpenAlex)
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Metastatic breast cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Registry name variants (4)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Barts Cancer Institute
London, EC1A 7BE
4 trials
Barts Cancer Institute, Centre of Experimental Cancer Medicine
London, EC1M 6BQ
1 trial
Contact: Peter Schmid, MD PhD, FRCP
Barts Cancer Institute - Haemato-Oncology
London, EC1M 6BQ
1 trial
Barts Cancer Institute (Site 1500)
London, EC1M 6BQ
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Bladder cancer40 works · 0 trials
- Kidney cancer36 works · 0 trials
- Triple-negative breast cancer24 works · 3 trials
- Metastatic breast cancer15 works · 4 trials
- Testicular cancer4 works · 0 trials
Institution data: ROR 0266wrt04 (CC0-1.0)Updated 15 Nov 2026